COVID-19: physIQ is answering the call for health systems and clinical trials. Click here to learn more.

Who We Are

PhysIQ is laser focused on providing solutions that meet strict FDA requirements — all while pioneering the power of the IoT and expanding our transformational proprietary analytics.

Zafi Avnur, PhD

Dr. Avnur is the Chief Scientific officer at Quark Venture Inc., a venture investment fund focused on life sciences investments. Prior to Quark, Zafi was the Global Head of Academic Innovation for Roche Partnering, responsible for creating relationships with the world’s leading academic institutions and world class innovators, gaining early access to innovation. In that role, she created nine startup companies. Preceding her academic innovation leadership role, Ms. Avnur was based in Basel, Switzerland, working in both diagnostics and pharmaceutical research, progressing from scientist and manager to assuming global responsibilities. At Roche, she contributed to the PHC (Personalized Health Care) initiative and oversaw the advancement of a number of compounds from the bench to clinical studies, to characterize the pharmacodynamics and clinical effects. Ms. Avnur was named Distinguished Scientist, the highest scientific appointment at Roche, holds a post doctorate (Cancer Biology) from Stanford University, and a Ph.D. from Weizmann Institute (Cell Biology).

Contact us and transform the future of real-world patient insight.

At physIQ, we welcome the opportunity to speak with potential customers, partners or anyone with an interest in learning more about the transformative potential of our technology.

Contact Us